DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18994
| null |
Remternetug
|
2571940-41-3
|
A5HTA4J6ME
|
Remternetug
| null |
DB18995
| null |
Rademikibart
|
2648260-80-2
|
NWV8DWU7QM
|
Rademikibart
| null |
DB18996
| null |
Povetacicept
|
2490217-42-8
|
EN2U82XV65
|
Povetacicept
| null |
DB18997
| null |
Plozasiran
|
2379776-40-4
|
XG9ARL6P25
|
Plozasiran
| null |
DB18998
| null |
Pemvidutide
|
2538014-94-5
|
A35F525WBG
|
Pemvidutide
| null |
DB18999
| null |
Pegtarviliase
|
2649372-23-4
|
RKK4N4FPA4
|
Pegtarviliase
| null |
DB19000
| null |
Nelmastobart
|
2669823-48-5
|
2S69ME4B3R
|
Nelmastobart
| null |
DB19001
| null |
Olpasiran
|
2225856-03-9
|
8M4GC1EOB4
|
ALL-P-AMBO-5'-O-((25S,30S)-39-((2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-25,30-BIS((2-(2-((2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)ETHOXY)ETHYL)CARBAMOYL)-1,23,28,33-TETRAOXO-1-SULFANYL-2,5,8,11,14,17,20,37-OCTAOXA-24,29,34-TRIAZA-1.L
| null |
DB19002
| null |
Narlumosbart
|
2646587-68-8
|
J38KT46AH8
|
Narlumosbart
| null |
DB19003
| null |
Mivelsiran
|
2572991-83-2
|
39CFL75KXH
| null | null |
DB19004
| null |
BMS-741672
|
1386991-77-0
|
3UAA36FHF1
|
N-(5-(ISOPROPYL(METHYL)AMINO)-2-(2-OXO-3-((6-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL)AMINO)PYRROLIDIN-1-YL)CYCLOHEXYL)METHANESULFONAMIDE
|
PJTGSIKANITYOO-RCOXNQKVSA-N
|
DB19005
| null |
AGI-134
|
1821461-84-0
|
OE0L4ZX3I8
|
2R)-1-((2-(5-((3-(((2R,3R,4R,5S,6R)-5-(((2S,3R,4S,5S,6R)-3,5-DIHYDROXY-6-(HYDROXYMETHYL)-4-(((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)OXAN-2-YL)OXY)-3-ACETAMIDO-4-HYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)PROPYL)CARBAMOYL) PENTANAMI
|
ZJYQGJWRGLACDM-UNBAAJOISA-N
|
DB19006
| null |
Vepdegestrant
|
2229711-68-4
|
WC1U3R1YMI
|
2,6-piperidinedione, 3-(1,3-dihydro-1-oxo-5-(4-((1-(4-((1r,2s)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl)phenyl)-4-piperidinyl)methyl)-1-piperazinyl)-2h-isoindol-2-yl)-, (3s)-
|
TZZDVPMABRWKIZ-XMOGEVODSA-N
|
DB19007
| null |
BMS-986251
|
2041841-30-7
|
2WQX2MS3MQ
|
(1R,3S,4R)-4-((3AR,9BR)-9B-((4-FLUOROPHENYL)SULFONYL)-7-(PERFLUOROPROPAN-2-YL)-2,3,3A,4,5,9B-HEXAHYDRO-1H-BENZO(E)INDOLE-3-CARBONYL)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID
|
JQORWGARJVSRBA-QOTTZFGFSA-N
|
DB19008
| null |
D3S-001
|
2706637-43-4
|
PFW9YLB86H
|
2-PIPERAZINEACETONITRILE, 4-(7-(3-AMINO-2-FLUORO-5-METHYL-6-(TRIFLUOROMETHYL)PHENYL)-2-(((2R,7AS)-2-FLUOROTETRAHYDRO-1H-PYRROLIZIN-7A(5H)-YL)METHOXY)-7,8-DIHYDRO-5H-PYRANO(4,3-D)PYRIMIDIN-4-YL)-1-(2-FLUORO-1-OXO-2-PROPEN-1-YL)-, (2S)-
|
JOLORSRKBHXPFT-PNGHJTAWSA-N
|
DB19009
| null |
Lunsekimig
|
2770858-49-4
|
VYR5R5XN5A
|
Lunsekimig
| null |
DB19010
| null |
Supinoxin
|
888478-45-3
|
ZU8OM8V5WF
|
1-(3,5-dimethoxyphenyl)-4-((6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl) piperazine | 1-piperazinecarboxamide, 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-2-quinoxalinyl)- | 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-quinoxalin-2-yl)piperazine-1-carboxamide | P-p68 inhibitor rx-5902
|
KAKPGJJRYRYSTP-UHFFFAOYSA-N
|
DB19011
| null |
Lepunafusp alfa
|
2396411-71-3
|
529C45O9XV
|
Lepunafusp alfa
| null |
DB19012
| null |
Efruxifermin
|
2375240-92-7
|
C1KR8TZ3NE
|
Immunoglobulin g (synthetic human constant domain fc fragment) fusion protein with fibroblast growth factor 21 (98-arginine,171-glycine,180-glutamic acid) (human mutant clone amg876) | Immunoglobulin g1 (human .gamma.1-chain c-region c-terminal fragment) fusion protein with peptide linker (ggggs)3 fusion protein with fibroblast growth factor 21 (98-arginine,171-glycine,180-glutamic acid) (human), dimer
| null |
DB19013
| null |
Insulin efsitora alfa
|
2131038-11-2
|
OZ465SMQ28
|
Insulin efsitora alfa
| null |
DB19014
| null |
Imdusiran
|
2839476-19-4
|
256UZ34AF2
|
Imdusiran
| null |
DB19015
| null |
Forimtamig
|
2649379-96-2
|
1GK8Z1OT1R
|
Forimtamig
| null |
DB19016
| null |
Equecabtagene autoleucel
| null | null |
autologous T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human B cell maturation antigen (BCMA) | Eque-cel | Equecabtagene autoleucel
| null |
DB19017
| null |
Eltrekibart
|
2484883-56-7
|
WB62WIH13E
|
Eltrekibart
| null |
DB19018
| null |
Elebsiran
|
2648009-64-5
|
W982Y6N4X7
|
Elebsiran
| null |
DB19019
| null |
Ecnoglutide
|
2459531-73-6
|
KM6YM7L8LH
|
Ecnoglutide
| null |
DB19020
| null |
Bovhyaluronidase azoximer
|
1383710-57-3
|
43VB0F6WF9
|
Bovhyaluronidase azoximer
| null |
DB19021
| null |
Bevonescein
|
2276787-79-0
|
5RG113V7K3
|
Bevonescein
| null |
DB19022
| null |
L-377202
|
207395-85-5
|
VDXVABRQTV
|
5-((2s,4r)-2-(((1s)-2-(((1s)-2-(((1s)-2-(((1s)-4-amino-1-(((1s)-1-(hydroxymethyl)-2-(((1s)-1-(((2s,3s,4s,6r)-3-hydroxy-2-methyl-6-(((1s,3s)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl)oxy)tetrahydropyran-4-yl) | 5,12-NAPHTHACENEDIONE, 10-((3-(((4R)-1-(4-CARBOXY-1-OXOBUTYL)-4-HYDROXY-L-PROLYL-L-ALANYL-L-SERYL-(2S)-2-CYCLOHEXYLGLYCYL-L-GLUTAMINYL-L-SERYL-L-LEUCYL)AMINO)-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYD
|
CZXGBIFEWYVYJY-NPLULESDSA-N
|
DB19023
| null |
Chiglitazar
|
743438-45-1
|
E6EJV1J6Y0
|
(2s)-3-(4-(2-carbazol-9-ylethoxy)phenyl)-2-(2-(4-fluorobenzoyl)anilino)propanoic acid | Carfloglitazar, (s)- | L-tyrosine, o-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)- | O-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)-l-tyrosine
|
QNLWMPLUWMWDMQ-YTTGMZPUSA-N
|
DB19024
| null |
DA-8031
|
1148027-74-0
|
VN9EXL272Y
|
1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)-5-ISOBENZOFURANCARBONITRILE | 5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)- | ISOBENZOFURANCARBONITRILE
|
RCMIUWUYNFSCAE-UHFFFAOYSA-N
|
DB19025
| null |
Dazodalibep
|
2245953-10-8
|
HN5US76BWF
|
PROTEIN VIB4920 (RECOMBINANT HUMAN TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 19-AMINO ACID LINKER) FUSION PROTEIN WITH TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN (HUMAN
| null |
DB19026
| null |
.gamma.-brain natriuretic peptide
|
114471-18-0
|
07Y2V56IUP
|
Brain natriuretic peptide | Natriuretic peptides b | Natriuretic peptides b (human)
| null |
DB19027
| null |
Arterolane
|
664338-39-0
|
3N1TN351VB
|
Dispiro(cyclohexane-1,3'-(1,2,4)trioxolane-5',2''-tricyclo(3.3.1.13,7)decane)-4-acetamide, n-(2-amino-2-methylpropyl)-, cis-
|
VXYZBLXGCYNIHP-ACBWXVLLSA-N
|
DB19028
| null |
Atamparib
|
2381037-82-5
|
B1MW2ME77A
|
3(2h)-pyridazinone, 5-(((1s)-1-methyl-2-(3-oxo-3-(4-(5-(trifluoromethyl)-2-pyrimidinyl)-1-piperazinyl)propoxy)ethyl)amino)-4-(trifluoromethyl)- | 5-(((2s)-1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2- yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4- (trifluoromethyl)pyridazin-3(2h)-one
|
UQZCQKXJAXKZQH-LBPRGKRZSA-N
|
DB19029
| null |
Atuliflapon
|
2041075-86-7
|
NV6352Y6TV
|
(1r,2r)-2-(4-(3-methyl-1h-pyrazol-5-yl)benzoyl)-n-(4-oxo-6,7-dihydro-5h-pyrazolo(1,5-a)pyrazine-3-yl)cyclohexanecarboxamide | Cyclohexanecarboxamide, 2-(4-(5-methyl-1h-pyrazol-3-yl)benzoyl)-n-(4,5,6,7-tetrahydro-4-oxopyrazolo(1,5-a)pyrazin-3-yl)-, (1r,2r)-
|
ROTWSDMXHVGAHZ-QZTJIDSGSA-N
|
DB19030
| null |
Atuzaginstat
|
2211981-76-7
|
DGN7ROZ8EN
|
Cyclopentanecarboxamide, n-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)- | N-((3s)-7-amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide
|
OLIMBXKACVCIMM-HNNXBMFYSA-N
|
DB19031
| null |
Azafenidin
|
68049-83-2
|
XQK9668H5M
|
2-(2,4-dichloro-5-(2-propynyloxy)phenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-a)pyridin-3(2h)-one | 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-a)pyridin-3(2h)-one | Evolus | Milestone
|
XOEMATDHVZOBSG-UHFFFAOYSA-N
|
DB19032
| null |
Bavdegalutamide
|
2222112-77-6
|
H6NYM0V650
|
3-pyridazinecarboxamide, n-(trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1h-isoindol-5-yl)-1-piperazinyl)methyl)-1-piperidinyl)- | Arv-110 (protac) | N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxo-2,3-dihydro-1h-isoindol-5-yl)piperazin-1-yl)methyl)piperidin-1-yl)pyridazine-3-carboxamide
|
CLCTZVRHDOAUGJ-SYVGMNBRSA-N
|
DB19033
| null |
Befiradol
|
208110-64-9
|
RAT9OHA1YH
|
(2E)-2-butenedioate | (3-chloro-4-fluorophenyl)(4-fluoro-4-((((5-methylpyridin-2-yl)methyl)amino)methyl)piperidin-1-yl)methanone | 4-piperidinemethanamine
|
PKZXLMVXBZICTF-UHFFFAOYSA-N
|
DB19034
| null |
Mevidalen
|
1638667-79-4
|
4A3702A96F
|
2-(2,6-dichlorophenyl)-1-((1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl)ethanone | Ethanone, 2-(2,6-dichlorophenyl)-1-((1s,3r)-3,4-dihydro-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-2(1h)-isoquinolinyl)-
|
XHCSBQBBGNQINS-DOTOQJQBSA-N
|
DB19035
| null |
Bersacapavir
|
1638266-40-6
|
2456KW2166
|
1h-pyrrole-2-carboxamide, n-(3-cyano-4-fluorophenyl)-1-methyl-4-((((1s)-2,2,2-trifluoro-1-methylethyl)amino)sulfonyl)- | N-(3-cyano-4-fluorophenyl)-1-methyl-4-(((2s)-1,1,1-trifluoro-2-propanyl)sulfamoyl)-1hpyrrole-2-carboxamide
|
SBVBIDUKSBJYEF-VIFPVBQESA-N
|
DB19036
| null |
Mizagliflozin
|
666843-10-3
|
1X96A704XV
|
3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(propan-2-yl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamide | Propanamide, 3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(1-methylethyl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethyl-
|
LREHMKLEOJAVMQ-TXKDOCKMSA-N
|
DB19037
| null |
Cofirasersen
|
2247669-96-9
|
XV92IM2BG0
|
Dna, d(p-thio)((2'-o,4'-c-((s)-ethylidene))m5rc-(2'-o,4'-c-((s)-ethylidene))m5rc-(2'-o,4'-c-((s)-ethylidene))m5rc-g-a-t-a-g-m5c-t-g-g-t-(2'-o,4'-c-((s)-ethylidene))m5ru-(2'-o,4'-c-((s)-ethylidene))rg-(2'-o,4'-c-((s)-ethylidene))m5ru) | DNA, D(P-THIO)((2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)M5C-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)M5C-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)M5C-G-A-T-A- | Ionis-enacrx
| null |
DB19038
| null |
Narazaciclib
|
1357470-29-1
|
QJ8RO3296G
|
Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-
|
VADOZMZXXRBXNY-UHFFFAOYSA-N
|
DB19039
| null |
Navocaftor
|
2159103-66-7
|
W2F2XU189O
|
(5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)methanol | 1,3,4-oxadiazole-2-methanol, 5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-pyridinyl)-
|
WOXOLLSAICIZNO-UHFFFAOYSA-N
|
DB19040
| null |
Nelonicline
|
1026134-63-3
|
WX8LOM674D
|
2-((3r,4s,5s,7s)-1-azaadamantan-4-yloxy)-5-phenyl-1,3,4-thiadiazole, rel-
|
QZDCYUCETTWCMO-WTGKZIDZSA-N
|
DB19041
| null |
Elimusertib
|
1876467-74-1
|
7N13IK9LNH
|
1,7-naphthyridine, 2-((3r)-3-methyl-4-morpholinyl)-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)-
|
YBXRSCXGRPSTMW-CYBMUJFWSA-N
|
DB19042
| null |
Orismilast
|
1353546-86-7
|
JH1CX8SG5V
|
2-(3,5-dichloro-1-oxido-4-pyridinyl)-1-(7-(difluoromethoxy)-2',3',5',6'-tetrahydro-1',1'-dioxidospiro(1,3-benzodioxole-2,4'-(4h)thiopyran)-4-yl)ethanone
|
ZININGNRPUGNSL-UHFFFAOYSA-N
|
DB19043
| null |
Imlunestrant
|
2408840-26-4
|
9CXQ3PF69U
|
(5r)-5-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(trifluoromethyl)-5h-(1)benzopyrano(4,3-c)quinolin-2-ol | 5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5-(4-(2-(3-(fluoromethyl)-1-azetidinyl)ethoxy)phenyl)-8-(trifluoromethyl)-, (5r)-
|
UVBQMXOKKDCBJN-MUUNZHRXSA-N
|
DB19044
| null |
Irsenontrine
|
1429509-82-9
|
54QB00NNRB
|
4h-pyrazolo(4,3-c)quinolin-4-one, 1,5-dihydro-7-(2-methoxy-3,5-dimethyl-4- pyridinyl)-1-((3s)-tetrahydro-3-furanyl)- | 7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-((3s)-tetrahydrofuran-3-yl)-1,5-dihydro-4h-pyrazolo(4,3-c)quinolin-4-one
|
CKJDCNZBABIEBZ-HNNXBMFYSA-N
|
DB19045
| null |
Lartesertib
|
2495096-26-7
|
KL7B6D38VC
|
2H-Imidazo[4,5-c]quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-, (1S)- | 8-(1,3-dimethyl-1h-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-2h-imidazo(4,5-c)quinolin-2-one
|
WNEFOSMCGCLLJU-UHFFFAOYSA-N
|
DB19046
| null |
Lazuvapagon
|
2379889-71-9
|
CK6VS66Q6X
|
(4s)-n-((2s)-1-hydroxypropan-2-yl)-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-2,3,4,5-tetrahydro-1h-1-benzazepine-4-carboxamide | 1h-1-benzazepine-4-carboxamide, 2,3,4,5-tetrahydro-n-((1s)-2-hydroxy-1-methylethyl)-4-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-, (4s)-
|
BKHSWGKGWGWMSM-CCLHPLFOSA-N
|
DB19047
| null |
Leflutrozole
|
143030-47-1
|
RCX0IE6EJZ
|
4,4'-(fluoro-1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
|
PZDLRBUQYWMNBR-UHFFFAOYSA-N
|
DB19048
| null |
BNC-210
|
1020634-41-6
|
QP49AY37OY
|
1,8-NAPHTHYRIDIN-4(1H)-ONE, 6-((2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-ETHYL-3-(4-MORPHOLINYLCARBONYL)- | 6-((2,3-dihydro-1h-inden-2-yl)amino)-1-ethyl-3-(4-morpholinylcarbonyl)-1,8-naphthyridin-4(1h)-one
|
ZAEIHDZLLJCJFP-UHFFFAOYSA-N
|
DB19049
| null |
IP-2018
|
881387-68-4
|
60XT58V8NZ
|
2h-1-benzopyran-2-one, 7-((3-exo)-8-azabicyclo(3.2.1)oct-3-yloxy)- | 7-((3-exo)-8-azabicyclo(3.2.1)oct-3-yloxy)-2h-1-benzopyran-2-one
|
PGUDASZQLOAZRX-DABQJJPHSA-N
|
DB19050
| null |
Bemnifosbuvir
|
1998705-64-8
|
7UM3SQL968
|
(s)-isopropyl 2-((s)-(((2r,3r,4r,5r)-5-(2-amino-6-(methylamino)-9h-purin-9-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate | At-527 free base | L-alanine, n-((p(s),2'r)-2-amino-2'-deoxy-2'-fluoro-n,2'-dimethyl-p-phenyl-5'-adenylyl)-, 1-methylethyl ester | N-((p(s),2'r)-2-amino-2'-deoxy-2'-fluoro-n,2'-dimethyl-p-phenyl-5'-adenylyl)-l-alanine 1-methylethyl ester
|
OISLSHLAXHALQZ-LZEIJKKFSA-N
|
DB19051
| null |
Zandatrigine
|
2154406-04-7
|
SV2WPA4R4J
|
Benzenesulfonamide, 2-fluoro-5-methyl-4-(methyl((3s)-1-(phenylmethyl)-3-pyrrolidinyl)amino)-n-4-thiazolyl-
|
UCSHINHOAVARGQ-SFHVURJKSA-N
|
DB19052
| null |
CH-1504 L-isomer
|
227016-66-2
|
86T288K8BS
|
(2s)-2-((4-(2-(2,4-diaminoquinazolin-6-yl)ethyl)benzoyl)amino)-4-methylene-pentanedioic acid | 4-methylene-n-(4-(2-(2,4-diaminoquinazolin-6-yl)ethyl)benzoyl)-l-glutamic acid | L-glutamic acid, n-(4-(2-(2,4-diamino-6-quinazolinyl)ethyl)benzoyl)-4-methylene- | L-m-trex | L-mobiletrex
|
NAWXUBYGYWOOIX-SFHVURJKSA-N
|
DB19053
| null |
Udifitimod
|
1883345-06-9
|
283FTA936D
|
((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol | [(1R,3S)-1-amino-3-{(6S)-6-[2-(2-methoxyphenyl)ethyl]- 5,6,7,8-tetrahydronaphthalen-2-yl}cyclopentyl]methanol | Cyclopentanemethanol, 1-amino-3-((6s)-5,6,7,8-tetrahydro-6-(2-(2-methoxyphenyl)ethyl)-2-naphthalenyl)-, (1r,3s)-
|
QCMHGCDOZLWPOT-FMNCTDSISA-N
|
DB19054
| null |
Deudextromethorphan
|
1079043-55-2
|
427476LZFT
|
(+)-3-d3-methoxy-17-d3-methyl-(9.alpha.,13.alpha.,14.alpha.)-morphinan | D6-dextromethorphan | Dextromethorphan d6 | Morphinan, 3-(methoxy-d3)-17-(methyl-d3)-, (9.alpha.,13.alpha.,14.alpha.)-
|
MKXZASYAUGDDCJ-QNNIAVNKSA-N
|
DB19055
| null |
Deudomperidone
|
2121525-08-2
|
HN0VIB0W8W
|
2h-benzimidazol-2-one-4,5,6,7-d4, 1-(3-(4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1-piperidinyl)propyl)-1,3-dihydro- | 3-(3-(4-(5-chloro-2-oxo-3hbenzimidazol-1-yl)-1- piperidyl)propyl)-4,5,6,7- tetradeutero-1h-benzimidazol-2- one
|
FGXWKSZFVQUSTL-GYABSUSNSA-N
|
DB19056
| null |
Deupirfenidone
|
1093951-85-9
|
1QC36BHI6S
|
1-phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one | 2(1h)-pyridinone, 5-(methyl-d3)-1-phenyl-
|
ISWRGOKTTBVCFA-FIBGUPNXSA-N
|
DB19057
| null |
Deutarserine
|
103292-62-2
|
OD54L0MH86
|
D-serine-2-d
|
MTCFGRXMJLQNBG-LIIDHCAMSA-N
|
DB19058
| null |
Iclepertin
|
1421936-85-7
|
M43ZDU10DD
|
[5-(Methylsulfonyl)-2-[(1R)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1R,5R)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]methanone | Methanone, (5-(methylsulfonyl)-2-((1r)-2,2,2-trifluoro-1-methylethoxy)phenyl)((1r,5r)-1-(5-(trifluoromethyl)-3-isoxazolyl)-3-azabicyclo(3.1.0)hex-3-yl)-
|
MYHDQTVHHMSLEF-DDBGAENHSA-N
|
DB19059
| null |
Iltamiocel
| null |
QTA2A5N6BE
|
AMDC | AMDC-USR | COOK MYOSITES AUTOLOGOUS MUSCLE DERIVED CELLS (AMDC) ARE EXPANDED (AMPLIFIED) THROUGH A TWO-PHASE MANUFACTURING PROCESS. THE EXPANSION IS CONSISTENT WITH ROUTINE CELL CULTURE PRACTICES FOR ADHERENT CELLS. DURING ADHERENT CELL CULTURE EXPANSION, CELLS REP
| null |
DB19060
| null |
Lomvastomig
|
2648840-52-0
|
9GAH9VG7IP
|
Anti-pd-1/tim-3 bispecific antibody ro7121661
| null |
DB19061
| null |
Nezastomig
|
2657613-60-8
|
M355PGI1TG
|
Anti-psma/cd28 bispecific antibody regn5678
| null |
DB19062
| null |
Pegozafermin
|
2489589-60-6
|
UO870O6MFS
|
Bio89-100 (long-acting glycopegylated fibroblast growth factor 21 (fgf21) analogue)
| null |
DB19063
| null |
Erzotabart
|
2430792-01-9
|
1I9AVY2IS7
|
gamma1 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV1-69*04 (93.8%) -(IGHD) -IGHJ3*02 (93.8%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121)-Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120 CH3 E12, M14, IGHG1v34 CH3 G109 (CH1 R120 (218) (122-219) | Immunoglobulin g1 (434-glycine), anti-(human cd38 antigen) (human monoclonal gen3014 .gamma.1-chain), disulfide with human monoclonal gen3014 .kappa.-chain, dimer | Immunoglobulin G1-kappa, anti-[Homo sapiens CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1)], Homo sapiens monoclonal antibody
| null |
DB19064
| null |
Danburstotug
|
2307144-65-4
|
F44C4N45HG
|
Immunoglobulin g1, anti-(human programmed death-ligand 1) (human monoclonal sti-3031 .gamma.1-chain), disulfide with human monoclonal sti-3031 .lambda.-chain, dimer
| null |
DB19065
| null |
Renvistobart
|
2725062-35-9
|
81J55YFQ16
|
Anti-TIGIT Monoclonal Antibody BMS-986207
| null |
DB19066
| null |
Belrestotug
|
2574438-65-4
|
59HAW3EQ4C
|
CLONE 31282 | Immunoglobulin g1, anti-(human receptor tigit) (human monoclonal eos884448 .gamma.1-chain), disulfide with human monoclonal eos884448 .kappa.-chain, dimer
| null |
DB19067
| null |
VIS-410
|
2043950-09-8
|
14WE3Z92C4
|
IMMUNOGLOBULIN G1, ANTI-(INFLUENZA HEMAGGLUTININ) (HUMAN MONOCLONAL VIS410 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIS410 .KAPPA.-CHAIN, DIMER
| null |
DB19068
| null |
IMT-288
|
637771-94-9
|
ECC868Y9YT
|
(4R)-5-(((1R)-1-CARBAMOYL-5-((2-((4-(2-(1H-IMIDAZOL-5-YL)ETHYLAMINO)-4-OXO-BUTANOYL)AMINO)ACETYL)AMINO)PENTYL)AMINO)-4-(((2R)-2-(((2R)-3-(4-HYDROXYPHENYL)-2-((2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAZACYCLODODEC-1-YL)ACETYL)AMINO)PROPANOYL)AMINO)-6-( | D-LYSINAMIDE, N-((4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL)ACETYL)-D-TYROSYL-N6-(N-(4-((2-(1H-IMIDAZOL-4-YL)ETHYL)AMINO)-1,4-DIOXOBUTYL)GLYCYL)-D-LYSYL-D-.ALPHA.-GLUTAMYL-N6-(N-(4-((2-(1H-IMIDAZOL-4-YL)ETHYL)AMINO)-1,4-DIOXOBUTYL)GLYCY
|
AUULGUVUMUKNPY-OGBYROOVSA-N
|
DB19069
| null |
Becotatug
|
2648260-93-7
|
981YA69AO3
|
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 γ1-chain), disulfide with human-Mus musculus monoclonal JMT101 κ-chain, dimer | Jmt101 (fully human monoclonal igg1 antibody targeting epidermal growth factor receptor (egfr))
| null |
DB19070
| null |
Aklavine
|
66676-88-8
|
T87WN25BNW
|
1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, methyl ester, (1r,2r,4s)- | Aclacinomycin | Aclacinomycin t
|
LJZPVWKMAYDYAS-QKKPTTNWSA-N
|
DB19071
| null |
Lerodalcibep
|
2250073-78-8
|
1PHP3QG5PZ
|
Engineered binding protein (1-96) anti-(human proprotein convertase subtilisin/kexin type 9), derived from human tenth fibronectin type iii domain, fused via peptidyl linker (97gsgsgs102) to human serum albumin (103-687), variant (c34>a136) | Protein lib003 (recombinant human proprotein convertase subtilisin/kexin type 9 ligand-binding tenth fibronectin type iii domain) fusion protein with peptide (synthetic 6-amino acid linker) fusion protein with serum albumin (34-alanine) (human)
| null |
DB19072
| null |
Letolizumab
|
1450981-87-9
|
449MIE2SD6
|
Immunoglobulin (synthetic light chain variable region fragment) fusion protein with immunoglobulin g (synthetic fc fragment), noncovalently linked dimer
| null |
DB19073
| null |
Levotofisopam
|
82059-51-6
|
11ZYL7QK34
|
(-)-(5s)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine | (s)-tofisopam | 5h-2,3-benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl, (5s)-
|
RUJBDQSFYCKFAA-OAHLLOKOSA-N
|
DB19074
| null |
Ligustrazine
|
1124-11-4
|
V80F4IA5XG
|
2,3,5,6-tetramethylpyrazine | Chuanxingzine | Chuanxiongqin | Ligustrazin | Pyrazine, 2,3,5,6-tetramethyl- | Pyrazine, tetramethyl- | Tetramethylpyrazine | Tetrapyrazine
|
FINHMKGKINIASC-UHFFFAOYSA-N
|
DB19075
| null |
KRN-330
| null |
A64J777I28
|
ANTI-A33 FULLY-HUMAN MONOCLONAL ANTIBODY | HUMAN MONOCLONAL ANTIBODY TO COLON CANCER ANTIGEN A33
| null |
DB19076
| null |
Lilotomab
|
1453362-55-4
|
58I6YNR7BV
|
Immunoglobulin g1, anti-(human cd antigen cd37) (mus musculus monoclonal hh1 heavy chain), disulfide with mus musculus monoclonal hh1 light chain, dimer
| null |
DB19077
| null |
Aminoflavone
|
165179-35-1
|
2EXS38428U
|
4h-1-benzopyran-4-one, 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl- | 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4h-1-benzopyran-4-one
|
RTUZVPPGTJRELI-UHFFFAOYSA-N
|
DB19078
| null |
Ensovibep
|
2451126-06-8
|
PV6AA88RDU
|
Designed ankyrin repeat protein (synthetic bivalent human albumin-binding) fusion protein with designed ankyrin repeat protein (synthetic trivalent severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor binding domain-binding)
| null |
DB19079
| null |
Fepixnebart
|
1799706-87-8
|
FP2PL0HRK8
|
IMMUNOGLOBULIN G4 (226-PROLINE,232-ALANINE,233-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN EPIREGULIN AND TRANSFORMING GROWTH FACTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL LY3016859 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY3016859 | Ly3016859 (humanized monoclonal antibody to human tgf.alpha. and epiregulin)
| null |
DB19080
| null |
Freneslerbart
|
2453195-94-1
|
AL6PH7LX2Y
|
Anti-cat allergen fel d 1 monoclonal anitbody regn-1908 | Immunoglobulin G4 [227-proline], anti-(Felis catus allergen Fel d1) (human monoclonal REGN1908 γ4-chain), disulfide with human monoclonal REGN1908 κ-chain, dimer
| null |
DB19081
| null |
Izokibep
|
2226130-02-3
|
8B8VV1W6FZ
|
Affibody aby-035 (recombinant human interleukin 17a-binding) | FUSION PROTEIN COMPOSED OF 3 BINDING DOMAINS CONSISTING OF THREE-ALPHA-HELIX MOTIFS, EACH DERIVED FROM THE IMMUNOGLOBULIN (IG)-BINDING Z-DOMAIN OF STAPHYLOCOCCAL PROTEIN A (SPA), ENGINEERED FOR BINDING TO TWO HOMODIMER SUBUNITS OF HUMAN INTERLEUKIN 17A (
| null |
DB19082
| null |
Botulinum Toxin Type E
| null |
T579M564JY
|
BONTOXILYSIN-E | BOTULINUM NEUROTOXIN SEROTYPE E (BONT/E) (EB-001) | BOTULINUM NEUROTOXIN TYPE E
| null |
DB19083
| null |
Mescaline
|
54-04-6
|
RHO99102VC
|
2-(3,4,5-trimethoxyphenyl)ethanamine | 3,4,5-trimethoxyphenethylamine
|
RHCSKNNOAZULRK-UHFFFAOYSA-N
|
DB19084
| null |
Metacavir
|
120503-45-9
|
W5EOS3V193
|
((2s,5r)-5-(2-amino-6-methoxy-purin-9-yl)tetrahydrofuran-2-yl)methanol | 2',3'-dideoxy-6-o-methylguanosine | Guanosine, 2',3'-dideoxy-6-o-methyl-
|
FJAOCNGVPLTSLD-NKWVEPMBSA-N
|
DB19085
| null |
Novolimus
|
151519-50-5
|
2719UAHUA8
|
16-o-demethylrapamycin | 16-o-demethylsirolimus | 7-o-demethylrapamycin | 7-o-demethylsirolimus | Rapamycin, 7-o-demethyl-
|
ZHYGVVKSAGDVDY-QQQXYHJWSA-N
|
DB19086
| null |
Oridonin
|
28957-04-2
|
0APJ98UCLQ
|
Isodonol | Kaur-16-en-15-one, 7,20-epoxy-1,6,7,14-tetrahydroxy-, (1.alpha.,6.beta.,7.alpha.,14r)- | Kaur-16-en-15-one, 7.alpha.,20-epoxy-1.alpha.,6.beta.,7,14-tetrahydroxy-, (14r)- | Oridonine | Pure oridonin
|
SDHTXBWLVGWJFT-XKCURVIJSA-N
|
DB19087
| null |
Shigella sonnei strain 53G
| null |
3JU3LM3632
| null | null |
DB19088
| null |
Asundexian
|
2064121-65-7
|
LA585UM8DE
|
1(2h)-pyridineacetamide, n-(4-(aminocarbonyl)-3-fluorophenyl)-4-(5-chloro-2-(4-(trifluoromethyl)-1h-1,2,3-triazol-1-yl)phenyl)-.alpha.-ethyl-5-methoxy-2-oxo-, (.alpha.s)-
|
XYWIPYBIIRTJMM-IBGZPJMESA-N
|
DB19089
| null |
Propionibacterium acnes
| null |
TRZ1AA965O
|
Bacillus acnes
| null |
DB19090
| null |
Baxdrostat
|
1428652-17-8
|
NF3P9Z8J5Y
|
(+)-(r)-n-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide | N-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)propanamide | Propanamide, n-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)-
|
VDEUDSRUMNAXJG-LJQANCHMSA-N
|
DB19091
| null |
Bleomycin A2
|
11116-31-7
|
13M89UEA7W
|
Bleogin | Bleomycinamide, n1-(3-(dimethylsulfonio)propyl)- | Pingyangmycin a2 | Zhengguangmycin a2
|
OYVAGSVQBOHSSS-UAPAGMARSA-N
|
DB19092
| null |
Modified vaccinia virus Ankara-85A antigen
|
2171576-44-4
|
H0QZ75H2XY
|
Modified vaccinia virus ankara-mycolyl transferase 85a (mycobacterium tuberculosis h37rv) expressing virus
| null |
DB19093
| null |
Lactobacillus crispatus strain CTV-05
| null |
RP8X0ZB061
|
Lactin-V | Lactobacillus crispatus (CTV-05)
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.